Lab21 Ltd.

Lab21 Ltd.

Founded 2005

Cambridge, United Kingdom 12 employees Venture round Total: $9.34M Biotechnology, Health Care +1

Lab21 Ltd. is a rapidly growing healthcare diagnostics business, founded in 2005 and headquartered in the United Kingdom. The company's vision is to provide personalized diagnostic testing for disease identification, disease predisposition, and personalized medicine, emphasizing the importance of prevention over cure. Lab21 operates in two main trading divisions. The first division focuses on molecular diagnostic testing services, particularly for patients needing diagnosis and optimized treatment in areas such as cancer and virology. Lab21's offerings encompass a wide range of services, including the handling of infectious samples in its Category 3 containment facilities. Notably, the company leads the market in providing companion diagnostic services and collaborates closely with major pharmaceutical companies. Furthermore, the company's reference lab is fully accredited for handling patient and clinical trial samples, and it has developed robust logistic services to transport samples globally. Lab21 also boasts significant experience in developing and commercializing new biomarker assays using its own or partner intellectual property. The second division centers on proprietary manufactured antibody and antigen-based products for infectious diseases, such as syphilis, CMV, TB, and malaria, which are distributed in worldwide blood banking and diagnostic product markets. The company's portfolio is continuously expanding, with a range of proprietary new and improved immuno- and molecular diagnostic products sold in over 100 countries through a combination of direct and indirect distribution channels. Lab21's impressive growth has been underscored by a recent £5.00M Venture Round investment in August 29, 2012, led by Clydesdale Bank. The company enjoys a strong position with four UK-based sites and the impending establishment of its US headquarters in South Carolina. With its revenues tripling in 2009 and a proactive strategy combining organic and acquisitive growth, Lab21 is poised for sustained success in the biotechnology, healthcare, and information technology industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	£5.00M	1	Clydesdale Bank	29 Aug 2012
Venture Round	$837.80K	-		27 Oct 2010
Series A	Undisclosed	-		20 Aug 2010
Venture Round	£1.30M	1	Medicis Capital	18 Mar 2009
Venture Round	€2.20M	-		05 Jan 2009

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

£5.00M

Clydesdale Bank

29 Aug 2012

Venture Round

$837.80K

27 Oct 2010

Series A

Undisclosed

20 Aug 2010

Venture Round

£1.30M

Medicis Capital

18 Mar 2009

Venture Round

€2.20M

05 Jan 2009

FAQ About Lab21 Ltd.

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better...

Lab21 Ltd. was founded in 2005.

Lab21 Ltd. is headquartered in Cambridge, United Kingdom.

Lab21 Ltd. operates in Biotechnology, Health Care and Information Technology. Its work centres on healthcare diagnostics, molecular diagnostic testing, personalized medicine and companion diagnostic services.

Lab21 Ltd. has approximately 12 employees.

Lab21 Ltd. has completed 5 funding rounds, raising a total of $9.34M. The latest funding stage is Venture round.

Top alternatives and competitors to Lab21 Ltd. include Biocartis, Molecular Testing Labs, IMMY, Selah Genomics Inc, Crescendo Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Lab21 Ltd. and Biocartis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Lab21 Ltd.

Funding Rounds & Investors (5)

Lab21 Ltd. Alternatives & Competitors

FAQ About Lab21 Ltd.